Orthopedic Medical Device Dark Horse Successfully Launches IPO

On February 10, 2026, Suzhou AIDE Technology Development Co., Ltd. (stock ticker: AIDE Technology, stock code: 920180) was officially listed on the Beijing Stock Exchange (BSE), successfully transitioning from the NEEQ Select Tier (former code: 874400) to the BSE. This makes it another new listed company for Zhangjiagang City and Suzhou. The achievement of this milestone not only marks another breakthrough for the company in the capital market but also injects new vitality into its future industrial development and capital operations.

Aide Technology successfully raised approximately RMB 227 million through this transfer listing and plans to primarily use these funds for orthopedic consumables production expansion projects, R&D center construction, and marketing network expansion. Specifically, the funds will support the company in further investments in capacity enhancement, technological innovation, and market expansion, promoting the company's leading position in the orthopedic medical device field.

Regarding the offering size, Aide Technology publicly offered approximately 29.5308 million shares (precisely 29,530,762 shares) at an issue price of 7.67 yuan per share. The company's stock performed remarkably on its first day, with an opening surge of over 220%. It closed at 21.23 yuan per share, marking a 176.79% increase. The trading volume reached 553 million yuan, with a volatility of 62.19% and a turnover rate of 89.61%. The total market capitalization was approximately 2.508 billion yuan.

The success of this IPO not only provided Aidi Technology with the capital support needed for further development but also helped the company establish stronger market confidence within the industry, providing a powerful capital backing for its future business expansion and increased market share.

In terms of financial performance, AIDE Technology's financial reports show that the company achieved double-digit growth in 2025, with revenue reaching 302 million yuan, a year-on-year increase of 9.74%, and net profit of 77.7527 million yuan, a year-on-year increase of 15.82%. The company has strong profitability in its operations, with a year-on-year increase in net profit excluding non-recurring items of approximately 17.99%, demonstrating high earnings quality.

Especially in core areas such as minimally invasive spinal intervention and trauma repair, Aide Technology has maintained steady growth through technological innovation and market expansion. Despite facing certain market challenges in 2023, the company successfully achieved a steady recovery in 2024 and 2025 by adjusting strategies and strengthening product R&D. Particularly in the first half of 2025, Aide Technology's revenue and net profit grew by approximately 19.07% year-on-year, demonstrating its strong recovery momentum.

Since its establishment, Aike Technology has focused on the R&D, production, and sales of orthopedic medical devices, achieving significant breakthroughs particularly in spinal minimally invasive interventional techniques and trauma repair. The company boasts a rich product line covering spine, trauma, sports medicine, wound repair, and other fields, meeting various clinical needs.

The company possesses strong technological advantages in the field of minimally invasive spinal intervention. Vertebral augmentation systems are one of the company's early flagship products and currently rank among the top three in the domestic market. AIDE Technology's products not only meet domestic market demands but are also gradually expanding into international markets, having obtained multiple domestic and international certifications, including SFDA registration certificates, ISO13485, and EU CE certification.

Furthermore, Aidite's product portfolio is gradually expanding to niche areas such as trauma repair and sports medicine. In particular, the company is continuously increasing investment in the research and development and application of trauma and sports medicine products, constantly enriching its product line. Aidite is committed to becoming a comprehensive solution provider in the field of orthopedic medical devices through technological innovation and independent research and development.

Founded in 2006, Aidite has undergone multiple technological innovations and market breakthroughs. Through more than a decade of dedicated efforts, the company has gradually evolved from a small-scale enterprise focused on imitating imported products into one of the leading domestic orthopedic medical device companies.

2006: The company was established and headquartered in the Zhangjiagang Medical Device Industrial Park, focusing on the field of orthopedic medical devices.

2008-2012: The company's products obtained multiple certifications and gradually expanded market share, especially accumulating a leading market position in the spinal product category.

2015-2018: Completed shareholding system reform and renamed as Suzhou Aide Technology Development Co., Ltd., entered multiple new fields such as spinal internal fixation, trauma plates, and intramedullary nails, and received honors such as "Jiangsu High-tech Enterprise".

2019-2022: Introduced strategic investors; product market share ranked among the top six domestic independent brands in China. In 2022, an attempt at an IPO on the ChiNext board was unsuccessful, leading to a shift towards the Beijing Stock Exchange.

2024-2026: Listed on the New Third Board Select Layer, successfully transferred to the Beijing Stock Exchange (BSE) for listing, and further deepened the company's market layout.

This development fully demonstrates Aidite's deep accumulation in the field of orthopedic medical devices, as well as its ability to adapt flexibly to the ever-changing market environment.

Aide Technology's successful transfer to the Beijing Stock Exchange not only brings the company broader capital market resources, but also injects new vitality into its future development.

Through this IPO, AIDE Technology will gain more capital support, further enhance its brand influence, and propel the company to a higher level of development. In the future, with the continuous expansion of product lines and sustained improvement of technical level, AIDE Technology is expected to usher in broader growth opportunities in domestic and international markets.